AU2002321012B2 - A purification process for large scale production of Gc-globulin, product obtained thereby and their use in medicine - Google Patents

A purification process for large scale production of Gc-globulin, product obtained thereby and their use in medicine Download PDF

Info

Publication number
AU2002321012B2
AU2002321012B2 AU2002321012A AU2002321012A AU2002321012B2 AU 2002321012 B2 AU2002321012 B2 AU 2002321012B2 AU 2002321012 A AU2002321012 A AU 2002321012A AU 2002321012 A AU2002321012 A AU 2002321012A AU 2002321012 B2 AU2002321012 B2 AU 2002321012B2
Authority
AU
Australia
Prior art keywords
globulin
chromatography
virus
process according
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002321012A
Other languages
English (en)
Other versions
AU2002321012A1 (en
Inventor
Gunnar Houen
Charlotte Svaerke Jorgensen
Inga Laursen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Statens Serum Institut SSI
Original Assignee
Statens Serum Institut SSI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Serum Institut SSI filed Critical Statens Serum Institut SSI
Publication of AU2002321012A1 publication Critical patent/AU2002321012A1/en
Application granted granted Critical
Publication of AU2002321012B2 publication Critical patent/AU2002321012B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
AU2002321012A 2001-08-14 2002-08-12 A purification process for large scale production of Gc-globulin, product obtained thereby and their use in medicine Ceased AU2002321012B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101217 2001-08-14
DKPA200101217 2001-08-14
PCT/DK2002/000531 WO2003016348A2 (en) 2001-08-14 2002-08-12 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine

Publications (2)

Publication Number Publication Date
AU2002321012A1 AU2002321012A1 (en) 2003-05-29
AU2002321012B2 true AU2002321012B2 (en) 2008-07-24

Family

ID=8160667

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002321012A Ceased AU2002321012B2 (en) 2001-08-14 2002-08-12 A purification process for large scale production of Gc-globulin, product obtained thereby and their use in medicine

Country Status (9)

Country Link
EP (1) EP1419177B1 (enExample)
JP (1) JP2005508892A (enExample)
AT (1) ATE393780T1 (enExample)
AU (1) AU2002321012B2 (enExample)
CA (1) CA2456843A1 (enExample)
DE (1) DE60226327T2 (enExample)
DK (1) DK1419177T3 (enExample)
ES (1) ES2305272T3 (enExample)
WO (1) WO2003016348A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101005859B (zh) * 2004-06-29 2012-08-15 利莱恩斯生命科学有限公司 灭病毒生物液体的制备方法
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
US8129139B2 (en) * 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
NZ603616A (en) * 2010-05-18 2015-02-27 Abbvie Inc Apparatus and process of purification of proteins
WO2012029954A1 (ja) 2010-09-03 2012-03-08 国立大学法人徳島大学 新規Ｇｃグロブリンガラクトース脱糖体の製造方法
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
US10322147B2 (en) 2013-12-13 2019-06-18 Saisei Pharma Co., Ltd. Enzyme-treated bovine colostrum, preparation method thereof, composition, and foods and beverages
WO2015158776A1 (en) * 2014-04-15 2015-10-22 Boehringer Ingelheim International Gmbh Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product
US11464835B2 (en) * 2015-06-01 2022-10-11 Saisei Pharma Co., Ltd. Enzyme-treated milk product, preparation method thereof, composition, and products

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177002A (en) * 1989-11-20 1993-01-05 Nobuto Yamamoto In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor
ATE171625T1 (de) * 1990-04-11 1998-10-15 Brigham & Womens Hospital Therapeutische verwendung von actin-bindenden verbindungen
US6268478B1 (en) * 1996-02-12 2001-07-31 Cedars-Sinai Medical Center Intracellular vitamin D binding protein

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Hoffmann, R. et al (1990) Human Genetics 84:137-146 *
Osawa, M. et al (1992) Biochim. Biophys. Acta. 1117:271-278 *

Also Published As

Publication number Publication date
DE60226327D1 (de) 2008-06-12
DK1419177T3 (da) 2008-08-25
WO2003016348A2 (en) 2003-02-27
ATE393780T1 (de) 2008-05-15
WO2003016348A3 (en) 2004-03-04
EP1419177A2 (en) 2004-05-19
JP2005508892A (ja) 2005-04-07
DE60226327T2 (de) 2009-07-09
EP1419177B1 (en) 2008-04-30
CA2456843A1 (en) 2003-02-27
ES2305272T3 (es) 2008-11-01

Similar Documents

Publication Publication Date Title
US6806355B2 (en) Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
DK2270044T3 (en) Liquid immunoglobulin G (IgG) product
EP2270044B1 (en) Liquid immunoglobulin G (lgG) product
CN103153333B (zh) 补体因子h的纯化方法
AU2002321012B2 (en) A purification process for large scale production of Gc-globulin, product obtained thereby and their use in medicine
AU2002321012A1 (en) A purification process for large scale production of Gc-globulin, product obtained thereby and their use in medicine
AU764066B2 (en) Purification process for production of mannan-binding lectin and an MBL medicinal product
Lee Joergensen et al.
HK1151045B (en) Liquid immunoglobulin g (lgg) product
HK1151044B (en) Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products
MXPA00012230A (en) Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired